| Ytd | 157.81% | |
| 1y | 158.84% |
| Open | 19.94 | Prev Close | 19.52 | Low | 19.04 | High | 19.94 | Mkt Cap | 609.86M |
| Vol | 26.19K | Avg Vol | 220.60K | EPS | -1.31 | P/E | N/A | Forward P/E | -4.77 |
| Beta | 0.40 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 12.14 | 200-d Avg | 8.63 | 1yr Est | 22.00 |
Does Nuvectis Pharma, Inc. (NVCT) have what it takes to be a top stock pick for momentum investors?
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 242.5% to $2.77 during Tuesday&#
Gainers Abivax (NASDAQ:ABVX) shares increased by 36.0% to $130.74 during Tuesday's pre-market s
US stock futures up, Dow futures gain 100+ points. Concentrix Corp (CNXC) shares down 24% after weak
AeroVironment, Inc. (NASDAQ: AVAV) jumped 21.4% in pre-market trading after reporting strong financi
Nuvectis intends to use the net proceeds from the offering to continue to advance the development pr
FORT LEE, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical s
Gainers Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market
Nuvectis Pharma, Inc. (NASDAQ:NVCT), a clinical stage biopharmaceutical company focused on the devel
FORT LEE, NJ, June 29, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical sta
Nuvectis Pharma (NVCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg
NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.
HC Wainwright & Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:NVCT) with a B
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage
HC Wainwright & Co. analyst Joseph Pantginis maintains Nuvectis Pharma (NASDAQ:NVCT) with a B
Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
Although US stocks closed lower on Friday, there were a few notable insider trades.
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) gained 126.5% to settle at $2.65 on Tu
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursd